Oviva, the digital health scaleup provider of diet and lifestyle coaching to people who deal with diet-related health challenges, has raised $80 million in Series C funding to reach millions of people across Europe. The round
Tags :News
Damiani Group, an Italian luxury jewelry corporate group that designs, manufactures, distributes and sells jewelry and luxury watches, has appointed Manuela Eleonora D’Ippolito (pictured) in the role of legal specialist. She will be reporting
Allgemeine Baugenossenschaft Zürich (ABZ), a non-profit housing cooperative, launched and priced its issuance of CHF 120 million total nominal amount of 0.25% Sustainability Bonds 2021-2031. The bonds have been offered in full compliance with the Financial
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
CMS Switzerland welcomed Vaïk Müller (pictured) as a partner of the firm. In his new role, Müller will help develop the firm’s expertise in areas of banking & finance along with
Gxo Logistics, a global provider of transportation and logistics solutions, has appointed Maria Elena Scolaro (pictured) as head of legal affairs for Italy and Switzerland. Scolaro is reporting to general counsel for Europe and to
Vischer’s dispute resolution team successfully represented a Swiss bank in a multi-faceted conflict, defending against allegations of corruption and breaches of contract as well as massive claims for damages. The dispute included commercial court
The Geneva International Motor Show (GIMS) announced its strategic partnership with Qatar Tourism at a press conference held on 25 August 2021 at the Doha Exhibition & Convention Center. The parties have joined forces to develop and
Alnylam Pharmaceuticals, the RNAi therapeutics company, has promoted Francesco Vazzana (pictured) into the role of senior director, legal counsel international. Vazzana, who is based in Zug, Switzerland, will be reporting to Arianna Greco, Alnylam’s
Biopharmaceutical company Relief Theraputics Holding, has a binding agreement with two institutional U.S. investors completed. The contract provides for the purchase of Relief shares with a total value of CHF 15 million, which come from
